Versius Plus

Overview and Use Cases

The Versius Plus is a robotic-assisted surgical system designed for minimally invasive surgery (MIS). It is intended to support surgeons across multiple specialties, including general surgery, gynecology, urology, and thoracic procedures. The system allows surgeons to operate from an open, ergonomic console while controlling articulated robotic arms that replicate and refine hand movements inside the patient's body.

Key use cases include:

• Laparoscopic procedures such as cholecystectomy and colectomy
• Gynecological operations including hysterectomy
• Urological procedures
• Thoracic and upper gastrointestinal surgery

The modular design of the Versius platform is intended to allow flexible operating room setup, with individual arm units that can be repositioned between procedures.

Key Technical Features

The Versius Plus builds on the core architecture of the Versius system with reported enhancements in several areas. Specific technical specifications have not been fully disclosed in public documentation, but the system is understood to include:

• 3D high-definition visualization: A stereoscopic camera system providing surgeons with an immersive view of the operative field
• Wristed instrument articulation: Multi-degree-of-freedom instruments designed to replicate and enhance the dexterity of the human hand
• Open surgeon console: An ergonomically designed workstation intended to reduce fatigue during long procedures
• Modular robotic arms: Individual arm units that can be configured to suit different procedures and operating room layouts
• Haptic and motion-scaling feedback: Features aimed at improving surgical precision, though exact specifications are not publicly confirmed

As with the original Versius, the system is reportedly designed with a relatively compact footprint compared to some competing platforms.

Comparison to Related Systems

Within CMR Surgical: The Versius Plus is positioned as an evolution of the original Versius system, reportedly offering expanded procedural capability and improved ergonomics. The original Versius established CMR Surgical's modular, portable approach to robotic surgery, and the Plus variant is understood to extend that philosophy with enhanced performance.

Competitor context: The dominant competitor in robotic-assisted surgery is Intuitive Surgical's Da Vinci Surgical System, which has a long-established global installed base and a broad portfolio of instruments and procedures. The Versius platform, including the Versius Plus, is generally positioned as a more accessible and flexible alternative, with a modular design that may lower barriers to adoption for smaller or mid-sized hospitals. Other competitors in the soft-tissue robotic surgery space include systems from Medtronic (Hugo RAS) and Johnson & Johnson MedTech (Ottava, as of public reporting).

Market Context and Target Buyers

CMR Surgical has publicly stated an ambition to democratize robotic surgery by making systems available to a wider range of healthcare institutions globally. The Versius Plus is likely targeted at:

• Hospital systems seeking to establish or expand robotic surgery programs
• Institutions in markets where the cost and complexity of larger competing systems present barriers
• Surgical centers prioritizing operating room flexibility and multi-specialty use

Pricing details for the Versius Plus have not been publicly disclosed. CMR Surgical has historically offered flexible commercial models, including usage-based arrangements, which may lower upfront capital requirements for adopting institutions.

Deployments and Notable Customers

As of public reporting, CMR Surgical has deployed the Versius platform across hospitals in Europe, Asia, and other international markets. The company has reported a growing number of procedures performed on the Versius system globally. Specific customer names and deployment figures for the Versius Plus variant specifically have not been widely confirmed in public sources.

Future Outlook

The robotic-assisted surgery market is expected to continue growing as hospitals seek to improve surgical outcomes and expand minimally invasive options. CMR Surgical has indicated ongoing investment in expanding the procedural portfolio and geographic reach of the Versius platform. The Versius Plus represents the company's effort to remain competitive as larger players expand their own next-generation offerings. Regulatory clearances in additional markets and further instrument development are likely areas of focus for the platform going forward.